373528008: Neomycin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Glycoside (substance)\Aminoglycoside (substance)\Substance with aminoglycoside structure and antibacterial mechanism of action (substance)\Neomycin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Neomycin (substance)	Is a	antibiotique cutané	false	Inferred relationship	Some
Neomycin (substance)	Is a	Substance with aminoglycoside structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Neomycin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing only neomycin and triamcinolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Fluocinolone and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Hydrocortisone and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Hydrocortisone and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Lidocaine and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Gramicidin and neomycin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Neomycin only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Chlorhexidine and neomycin only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Neomycin only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Clobetasol and neomycin and nystatin only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Product containing only neomycin and triamcinolone in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only neomycin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Product containing only fluocinolone and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only betamethasone and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only hydrocortisone and neomycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Neomycin only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Neomycin 5 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin (substance)	Inferred relationship	Some	1
Neomycin 5 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin (substance)	Inferred relationship	Some	1
Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin (substance)	Inferred relationship	Some	1
Betamethasone- and neomycin-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing betamethasone and neomycin in nasal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Betamethasone and neomycin only product in nasal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Hydrocortisone and neomycin only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Neomycin- and prednisolone-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Neomycin- and prednisolone-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only neomycin and prednisolone in otic dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Neomycin and prednisolone only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin (substance)	Inferred relationship	Some	1
Betamethasone and neomycin only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Hydrocortisone- and neomycin-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Product containing hydrocortisone and neomycin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	1
Contact dermatitis caused by neomycin	Causative agent (attribute)	True	Neomycin (substance)	Inferred relationship	Some	1
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Neomycin (substance)	Inferred relationship	Some	1
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin (substance)	Inferred relationship	Some	1
Bacitracin- and neomycin- and sulfacetamide-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	2
Product containing only dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	3
Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Neomycin (substance)	Inferred relationship	Some	3
Product containing dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Neomycin (substance)	Inferred relationship	Some	3

Start Page 2 of 2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198828019	Neomycin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211996011	Neomycin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54041000195119	neomicina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
310021000077114	néomycine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
69181000195117	Neomycin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module